Suliqua

entity.node.canonical

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/screen-shot-2017-01-30-at-1.56.45-pm.png?itok=LQrGEhU9

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/screen-shot-2017-01-30-at-1.56.45-pm.png?itok=uxfuq_FK

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/screen-shot-2017-01-30-at-1.56.45-pm.png?itok=2xzYWkVo

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/screen-shot-2017-01-30-at-1.56.45-pm.png?itok=-Zw_VwbU

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/screen-shot-2017-01-30-at-1.56.45-pm.png?itok=ZuDyGKz_

<p>A basal insulin and GLP-1 agonist combo becomes available in the US and receives approval in Europe</p>
